Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The β-galactosidase reporter gene encodes the enzyme β-galactosidase, a glycoside hydrolase that cleaves lactose into glucose and galactose, and is most commonly used as a molecular biology reporter to monitor gene expression and regulatory events. Its activity can be detected using chromogenic or fluorescent substrates, making it a standard tool in molecular genetics, cell biology, and biotechnology. In humans and bacteria, native β-galactosidase also plays a physiologic role in carbohydrate metabolism, but when used as a reporter gene (often as LacZ), it is not a therapeutic target, and its primary relevance is experimental rather than clinical.
For inhibitors: competitive inhibition of enzyme activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on β-Galactosidase reporter gene (β-gal or sometimes LacZ).